Anika Therapeutics, Inc. 4
4 · Anika Therapeutics, Inc. · Filed Nov 9, 2016
Insider Transaction Report
Form 4
BOWER JOSEPH I
Director
Transactions
- Exercise/Conversion
Stock Appreciation Right
2016-11-07−1,540→ 0 totalExercise: $12.36→ Common Stock (1,540 underlying) - Tax Payment
Common Stock
2016-11-07$44.26/sh−431$19,076→ 38,082 total - Sale
Common Stock
2016-11-09$43.31/sh−40$1,732→ 37,542 total - Exercise/Conversion
Common Stock
2016-11-07$12.36/sh+1,540$19,034→ 38,513 total - Sale
Common Stock
2016-11-09$43.40/sh−500$21,700→ 37,582 total
Footnotes (3)
- [F1]Exercise of stock appreciation rights ("SARs") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016.
- [F2]Reflects 431 shares of common stock utilized to cover the exercise price of the above listed SARs award by the Reporting Person on November 7, 2016.
- [F3]Reflects an aggregate of 540 shares of common stock sold to satisfy tax obligations related to the exercise of the above listed SARs award by the Reporting Person on November 9, 2016.